Showing results (71-80 of 334) with videos related to
Sort By:
Pageof 34
Journal of Cardiovascular Pharmacology|January 1, 1990
Reversal of left ventricular hypertrophy: a desirable therapeutic goal?R E Schmieder, F H MesserliDrugs|January 1, 1985
Cardiovascular pathophysiology of essential hypertension: a clue to therapyF H Messerli, H O VenturaClinics in Geriatric Medicine|May 1, 1990
Antihypertensive therapy in the elderlyF H Messerli, C J LosemJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 21, 2001
The choice of first-line therapy: rationale for low-dose combinations of an angiotensin converting enzyme inhibitor and a diureticL H Opie, F H MesserliJournal of Human Hypertension|November 30, 2000
Hypertension and the heartR E Schmieder, F H MesserliThe American Journal of Medicine|April 27, 1992
Is the decrease in arterial pressure the sole factor for reduction of left ventricular hypertrophy?R E Schmieder, F H MesserliEuropean Heart Journal|July 24, 2001
Antihypertensive therapy and the risk of malignanciesE Grossman, F H Messerli, U GoldbourtThe American Journal of Cardiology|November 25, 2000
Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertensionF H Messerli, S Oparil, Z FengCurrent Hypertension Reports|September 12, 2000
Carcinogenicity of cardiovascular drugsE Grossman, F H Messerli, U GoldbourtThe American Journal of Cardiology|April 6, 1999
Does diuretic therapy increase the risk of renal cell carcinoma?E Grossman, F H Messerli, U GoldbourtPageof 34